Implicit Bioscience

Implicit Bioscience

Implicit Bioscience is developing groundbreaking immunotherapy treatments for serious, often fatal, diseases 👉 #IC14

Founded 2005

Australia 12 employees Venture round Total: $17.03M Biotechnology, Health Care

Implicit Bioscience Analysis

Name: Implicit Bioscience

Slogan: Implicit Bioscience is developing groundbreaking immunotherapy treatments for serious, often fatal, diseases 👉 #IC14

Description: Implicit Bioscience, founded in 2004, is an unlisted public company based in Brisbane and Seattle. Led by biopharma veterans including Prof. Peter Andrews AO and Prof. Ian Frazer AC FRS, the company aims to revolutionize treatment for severe, life-threatening diseases lacking effective therapies. Implicit Bioscience holds global rights to IC14, a biologic monoclonal antibody drug targeting CD14, a key regulator of immune response and brain cell protection. The company focuses on leveraging immunoneurology to address neurodegenerative and neurotraumatic diseases, particularly MND/ALS, by combating damaging inflammation.

Industries: Biotechnology, Health Care

Last Investment: $65.55K Venture Round investment on August 28, 2020

Investors: Not disclosed

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	$65.55K	-		28 Aug 2020
Venture Round	$367.23K	-		13 Sep 2019
Venture Round	$210.07K	-		15 Nov 2016
Pre Seed Round	$50.80K	-		16 Nov 2015
Pre Seed Round	Undisclosed	-		19 Dec 2013
Grant	$16.34M	1	Defense Threat Reduction Agency (DTRA)	22 Oct 2007

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

$65.55K

28 Aug 2020

Venture Round

$367.23K

13 Sep 2019

Venture Round

$210.07K

15 Nov 2016

Pre Seed Round

$50.80K

16 Nov 2015

Pre Seed Round

Undisclosed

19 Dec 2013

Grant

$16.34M

Defense Threat Reduction Agency (DTRA)

22 Oct 2007

FAQ About Implicit Bioscience

Implicit Bioscience is developing groundbreaking immunotherapy treatments for serious, often fatal, diseases 👉 #IC14

Implicit Bioscience was founded in 2005.

Implicit Bioscience is headquartered in Australia.

Implicit Bioscience operates in Biotechnology and Health Care. Its work centres on Immunotherapy, Biopharma, Drug development and Monoclonal antibody.

Implicit Bioscience has approximately 12 employees.

Implicit Bioscience has completed 6 funding rounds, raising a total of $17.03M. The latest funding stage is Venture round.

Top alternatives and competitors to Implicit Bioscience include VBL Therapeutics (Nasdaq:VBLT), Evelo Biosciences, Chemomab Therapeutics, Upstream Bio, DJS Antibodies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Implicit Bioscience and VBL Therapeutics (Nasdaq:VBLT) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Implicit Bioscience

Funding Rounds & Investors (6)

Implicit Bioscience Alternatives & Competitors

FAQ About Implicit Bioscience